Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Return on Capital Employed (2017 - 2020)

Historic Return on Capital Employed for Forte Biosciences (FBRX) over the last 4 years, with Q1 2020 value amounting to 105.2%.

  • Forte Biosciences' Return on Capital Employed fell 1046000.0% to 105.2% in Q1 2020 from the same period last year, while for Mar 2020 it was 105.2%, marking a year-over-year decrease of 1046000.0%. This contributed to the annual value of 1.15% for FY2019, which is 5800.0% down from last year.
  • Latest data reveals that Forte Biosciences reported Return on Capital Employed of 105.2% as of Q1 2020, which was down 1046000.0% from 1.65% recorded in Q4 2019.
  • In the past 5 years, Forte Biosciences' Return on Capital Employed ranged from a high of 0.39% in Q3 2017 and a low of 105.2% during Q1 2020
  • For the 4-year period, Forte Biosciences' Return on Capital Employed averaged around 8.9%, with its median value being 0.61% (2018).
  • Per our database at Business Quant, Forte Biosciences' Return on Capital Employed skyrocketed by 11300bps in 2018 and then plummeted by -1046000bps in 2020.
  • Over the past 4 years, Forte Biosciences' Return on Capital Employed (Quarter) stood at 0.47% in 2017, then dropped by -21bps to 0.57% in 2018, then tumbled by -188bps to 1.65% in 2019, then tumbled by -6278bps to 105.2% in 2020.
  • Its Return on Capital Employed was 105.2% in Q1 2020, compared to 1.65% in Q4 2019 and 1.93% in Q3 2019.